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Summary
Behaviours of several animal species have been linked to lunar periodicity. Evi-
dence for such links in humans is weak; however, recently, shorter sleep duration
was reported around full moon in two small samples of adults. As restrictions in
sleep duration have been shown to adversely affect glucose regulation and
physical activity to improve glucose regulation, one could speculate that
cardiometabolic risk factors might also be affected by the lunar phase. We retro-
spectively examined 795 Danish children, aged 8–11 years, with more than
13 000 24-h accelerometer recordings of activity and sleep as well as 2000
measurements of different cardiometabolic risk factors, including insulin sensitiv-
ity, appetite hormones and blood pressure, during nine lunar phases. During the
period around full moon, children were 5.0 and 3.2 min per day less active, slept
2.4 and 4.1 min per night longer, had 0.03 and 0.05 higher homeostatic model
assessment of insulin resistance and 0.6 and 0.8 mmHg higher mean arterial blood
pressure compared with days around half moon and new moon, respectively (all
P ≤ 0.02). Furthermore, ghrelin was lower and leptin was higher during the period
around full moon compared with days around half moon (both P < 0.001). The
results suggest that physical activity rather than sleep is responsible for the
metabolic alterations observed around full moon. However, we have no under-
standing of potential mechanisms that may mediate a potential true link between
childhood behaviour and the lunar cycle or confounders that may explain this,
apparently leading to fluctuation in a number of cardiometabolic risk markers
conjointly with lunar phases.
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Introduction
The term ‘lunacy’, derived from Luna, the Roman goddess
of the moon, has been used since ancient times to explain
behaviour and mental health. Folklore and even certain
instances of occupational lore suggest that the behaviours
of both humans and animals, including werewolves, are
affected by lunar phases. In particular, the period around
full moon has been associated with increased prevalence of
sleep problems, seizures, cardiovascular events, anti-social
behaviour and mental problems (1). Behaviours of several
animal species have been linked to lunar periodicity (2); the
phenomenon of the Palolo worms, which reproduce by
mass spawning during the last quarter of the moon, is one
of the best-known examples (3). Currently, the scientific
bases for such links in humans are weak. It has, however,
recently been reported that sleep duration was negatively
affected around full moon in two small samples of adults
(4,5). As restrictions in sleep duration have been shown to
adversely affect glucose regulation (6), one could speculate
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that cardiometabolic risk factors because of insufficient
amounts of quality sleep might be affected by the lunar
phase. Furthermore, physical activity has the potential to
improve glucose regulation (7) and, in addition to sleep,
could explain potential differences in metabolic health
during the lunar phases.
To test this myth, we retrospectively examined 795
Danish children, aged 8–11 years, having accelerometer-
determined sleep duration and daytime physical activity
behaviour. We collected data from a total of 13 762 nights
and 13 464 d and made more than 2000 measurements of
different cardiometabolic risk factors, including insulin
sensitivity, appetite hormones, inflammation, blood lipids
and blood pressure, in relation to the lunar phase.
Materials and methods
The initial sample comprised 834 of the 1021 invited third-
and fourth-grade students (8–11 years old) from nine
Danish municipal schools enrolled in the OPUS (Optimal
well-being, development and health for Danish children
through a healthy New Nordic Diet) school meal study.
The main aim of this cluster-randomized crossover study
was to investigate the potential health effects of a New
Nordic Diet served at school vs. the usual packed lunch
(control) (8). Measurements were performed at baseline
(August to November 2011), before the end of the first
dietary period (approximately 100 d later) and before the
end of the second dietary period (after another 100 d). As
the school meal intervention did not affect physical activity,
sedentary time and sleep duration (9), all three measure-
ment points were used in the present paper regardless of
randomization status. The present analytical sample com-
prised data from the 795 children having valid sleep,
daytime physical activity or cardiometabolic risk factors
from at least one of the three measurement periods as well
as a valid reporting of pubertal status at baseline resulting
in 13 464 observations of daytime activity, 13 762 obser-
vations of sleep duration and 2005 to 2148 observations of
cardiometabolic risk factors across nine moon cycles from
August to June. The study was approved by the Commit-
tees on Biomedical Research Ethics for the Capital Region
of Denmark (J.nr. H-1-2010-123). Child assent and written
informed parental consent of both custody holders were
obtained for all participants. The study was registered in
the www.clinicaltrials.gov database (no. NCT01457794).
Daytime activity and sleep duration
The children were asked to wear an ActiGraph™ tri-axis
accelerometer monitor (GT3X+ or GT3X, Pensacola, FL,
USA) tightly on the right hip using an elastic belt continu-
ously for seven consecutive days and eight nights; they were
only allowed to remove it during water activities (i.e. show-
ering or swimming). At the end of the observation period,
data were reintegrated to 60-s epochs and analysed using
ActiLife6 (ActiGraph, Pensacola, FL, USA). Before analysis
of physical activity and sedentary time, we removed: (i)
data between midnight and 6.00 a.m., as this was expected
to be non-awake time; (ii) periods of at least 15 min of
consecutive zero counts using tri-axial vector magnitudes
to remove non-wear time and non-awake time; and (iii)
consecutive wear time periods of less than 60 min to
remove non-awake time, as sleep for most children is char-
acterized by minor periods of movement that we did not
want to include in our analysis of daytime activity. Seden-
tary time, light physical activity and moderate-to-vigorous
physical activity were defined as all minutes showing ≤100
vertical cpm, 101–2295 vertical cpm and ≥2296 vertical
cpm, respectively; these are widely used cut-off points (10).
Daytime activity was only considered valid if monitor wear
time was at least 10 h per day.
The parents and children were instructed to keep logs for
bedtime (‘lights off’ and trying to sleep) and waking time
(‘lights on’) during the week in which the monitor was
worn. To estimate accelerometer-determined sleep dura-
tion, the self-reported bedtimes and waking times were
used as the possible window of sleep and accelerometer
data within this window were scored in ActiLife6 using the
algorithm by Sadeh et al. that counts minutes below a
certain activity threshold as sleep (11). This algorithm was
developed using wrist-worn monitors; however, we recently
tested the agreement between wrist and waist-worn
ActiGraph monitors using this algorithm and concluded
that waist-worn devices can provide a valid proxy measure
of sleep duration in epidemiological studies (12).
Anthropometry and cardiometabolic risk markers
Clinical measurements and venous blood sampling from
the antecubital vein were performed in the morning (time
interval: 7.25–10.45 a.m.) after an overnight fast in a
mobile laboratory. Whole blood glucose was analysed
immediately after sampling using a Hemocue Glucose 201
analyser (Hemocue Danmark, Brønshøj, Denmark) that
calculated plasma glucose concentrations from whole
blood concentrations. Heparinized blood and blood with
ethylenediaminetetraacetic acid were centrifuged at 2500 g
for 10 min at room temperature and aliquoted plasma was
stored at −80°C. Serum insulin, plasma triglycerides,
plasma cholesterols, plasma leptin and plasma ghrelin were
analysed according to standard protocols described else-
where (13,14). Plasma C-reactive protein (CRP; high sen-
sitive) was quantified on the Vitros 5.1 FS analyser (Ortho–
Clinical Diagnostics, Johnson & Johnson, Birkerød,
Denmark) with a lower CRP detection limit of 0.1 mg L−1.
Plasma interleukin (IL)-6 (high sensitive) and adiponectin
were measured in duplicate by enzyme-linked immune-
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sorbent assays (R&D Systems Europe Ltd., Abingdon,
UK). Homeostatic model assessment of insulin resistance
(HOMAIR) was calculated as plasma glucose (mmol L−1) ×
serum insulin (mmol L−1)/22.5 (15). The inter- and intra-
assay coefficients of variation were: 1.3% and 0.8% (CRP);
6.7% and 2.9% (IL-6); 9.2% and 3.7% (leptin); 11% and
3.8% (adiponectin); 9% and 3.7% (ghrelin); 1.8% and
1.2% (total cholesterol); and 1.9% and 1.2% (High-
density lipoprotein cholesterol). The inter-assay coefficients
of variation were 3.4% for glucose and 5.9% for insulin.
After 10 min of rest, blood pressure and heart rate were
measured three times in the supine position with an auto-
mated device (UA-787 Plus; A&D Medical, San Jose, CA,
USA) using two different cuff sizes (18–22 cm or
22–32 cm). A second device (ProBP 3400 Sure BP, Welch
Allyn Inc., New York, USA) was used for children with arm
circumferences <22 cm using three different cuff sizes (12–
16, 15–21 and 20–26 cm). The mean of the last two meas-
urements was used in the data analyses. The mean arterial
blood pressure was calculated as: 1/3 × systolic blood pres-
sure (mmHg) + 2/3 × diastolic blood pressure (mmHg).
Height (CMS Weighing Equipment LTD, London, UK) was
measured three times to the nearest millimetre and the
average was used. The children were weighed to the nearest
0.1 kg (Tanita BWB-800S, Tanita, Europe) while barefoot
and wearing light clothing. The prevalence of underweight,
normal-weight, overweight and obese children was calcu-
lated based on age- and sex-specific cut-offs defined to pass
through a body mass index of 18.5, 25 and 30 kg m−2 at 18
years of age (16,17). Total body fat was determined by
dual-energy X-ray absorptiometry (Lunar Prodigy; GE
Medical Systems, Madison, WI, USA) using Encore soft-
ware version 13.5 (Encore, Madison, WI, USA).
Questionnaire data
A baseline questionnaire ascertained age, gender, school
grade, highest education of the parents (divided into four
groups according to years of education: ≤10 years, 11–12
years, 13–16 years, ≥17 years) and number of parents born
in Denmark (proxy of ethnicity). A proxy of pubertal status
was self-reported (parent and child) based on breast devel-
opment among girls and pubic hair growth among boys on
a scale from 1 to 5 (18). A dichotomous variable indicating
whether or not the child had entered puberty was used in
the statistical analyses (1 or ≥2).
Statistical analysis
Descriptive characteristics of the study sample were pre-
sented as mean and standard deviation, median
(interquartile range) or as proportions. An available-case
linear mixed model with school, class and subject as
random effects and weekday, month, age, gender, Tanner
stage, number of parents born in Denmark and highest
education of parents as fixed effects was used to test lunar
rhythmicity in behaviour (sleep, sedentary time, light physi-
cal activity and moderate-to-vigorous physical activity) and
metabolic variables (HOMAIR, glucose, insulin, blood pres-
sure, ghrelin, leptin, CRP, IL-6, adiponectin, high-density
cholesterol, low-density cholesterol, triglycerides and
resting heart rate). Based on this model, we estimated the
adjusted behaviour/biomarker with full moon ±4 d (full
moon) as reference compared with ±5–9 d (half moon) and
±10–14 d (new moon) from nearest full moon. These clas-
sifications of lunar phases are identical to what have been
used in recently published papers (4,5,19) using informa-
tion from a full moon calendar (20). Estimates are pre-
sented as unstandardized regression coefficients (β) with
95% confidence intervals. Some metabolic variables were
positively skewed and were thus log-transformed for analy-
ses and back-transformed after analyses. Adjusting for the
fact that the three repeated measures came from baseline,
control and intervention did not affect the observed asso-
ciations between metabolic variables and lunar phases. Pre-
sented P-values were not adjusted for multiple testing but
significant associations vanishing after Bonferroni adjust-
ment were indicated. Pearson’s correlation coefficients
were obtained between sleep duration, moderate-to-
vigorous physical activity and HOMAIR using an average of
the three measurements obtained at baseline, day 100 and
day 200. Changes from summer to winter time (clock set
back by 1 h) and from winter to summer time were
excluded from data analysis. The level of significance was
set at P < 0.05 and statistical analyses were conducted
using STATA/IC 11.2 (Houston, TX, USA).
Results
Baseline characteristics of the children can be found in
Table 1. As shown in Table 2, accelerometer-determined
Table 1 Descriptive characteristics of the study population at baseline
(n = 788–793)
Variable Mean ± standard
deviation or proportions
Age (years) 10.0 ± 0.6
Gender (% boys) 51.8
Tanner stage (% 1/2/≥3) 65.6/27.5/6.9
Parents born in Denmark (% 0/1/2) 8.7/12.2/79.1
Highest education of parents (%)* 5.4/34.5/38.8/21.2
Body mass index status (% uw/nw/ow/ob)† 10.3/76.4/11.4/1.9
Data are presented as mean ± standard deviation or proportion.
*Highest education of parents: ≤10/11–12/13–16/≥17 years.
†Based on age- and sex-specific cut-offs defined to pass through body
mass index at 18.5, 25 and 30 kg m−2 at age 18 years (16,17);
uw/nw/ow/ob, underweight/normal weight/overweight/obese.
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moderate-to-vigorous physical activity was 5.0 and 3.2 min
per day lower (both P < 0.001) and sleep duration was 2.4
and 4.1 min per night longer (all P ≤ 0.02) at full moon
compared with half moon and new moon, respectively.
Cardiometabolic risk markers as HOMAIR, insulin,
glucose, mean arterial blood pressure and diastolic blood
pressure were all higher at full moon compared with half
moon and new moon (all P ≤ 0.04); HOMAIR was 0.05
higher at full moon compared with new moon. Further-
more, leptin was 1.2 pg mL−1 higher and ghrelin
29 pg mL−1 lower at full moon compared with half moon
(both P < 0.001). No differences according to lunar phase
were found for time spent sedentary, light physical activity,
CRP, IL-6, adiponectin, high-density lipoprotein choles-
terol, low-density lipoprotein cholesterol, triglycerides or
resting heart rate (all P > 0.15). In our investigation of
plausible connections between behaviours and metabolic
health, we tested and found a negative correlation between
moderate-to-vigorous physical activity and sleep duration
(r = −0.12, P = 0.01); between moderate-to-vigorous
physical activity and HOMAIR (r = −0.25; P < 0.001);
and between sleep duration and HOMAIR (r = −0.16;
P < 0.001) after adjustment of sleep duration and
moderate-to-vigorous physical activity, respectively.
Bonferroni adjustment resulted in non-significant differ-
ences in insulin (P = 0.08) and glucose (P = 0.06) between
full moon and half moon; however, all other significant
associations remained.
Discussion
This is the first study to demonstrate that variations in sleep
duration as well as in daytime physical activity are associ-
ated with the lunar circle (∼29.5 d) and, furthermore, that
a number of cardiometabolic risk markers fluctuated in
accordance with this. Contrary to what has been hypoth-
esized and recently shown in adults (4,5), children slept
somewhat longer around full moon. It should be noted
that, although this was statistically highly significant, the
fluctuation in sleep duration between lunar phases was
small and its biological relevance is questionable. However,
we found that children were also less physically active
during this period and furthermore that this coincided
with biologically meaningful differences in several
cardiometabolic risk factors, including lower insulin sensi-
tivity and higher blood pressure, while the blood lipid
profile, adiponectin and markers of inflammation were not
affected. In addition, we found lunar phase-associated vari-
ations in ghrelin and leptin in directions that could favour
a positive energy balance during the period around full
moon (21).
The negative correlation between moderate-to-vigorous
physical activity and sleep duration fits well with the obser-
vation that sleep is longest and activity lowest during full
moon. However, the differences in sleep duration were very
small compared with those differences seen for moderate-
to-vigorous physical activity and the negative correlation
Table 2 Behaviours and metabolic variables according to lunar phases (n = 751–793)
Variables Observations Mean ± standard deviation or
median (interquartile range)
Full moon† – half moon‡ Full moon† – new moon§
Behaviours
Moderate-to-vigorous PA (min per day) 13 464 41 (21; 68) −5.0 (−6.5; −3.6)** −3.2 (−4.7; −1.7)**
Light PA (min per day) 13 464 375 ± 80 0.1 (−3.0; 3.2) 1.7 (−1.4; 4.9)
Sedentary time (min per day) 13 464 477 ± 99 1.4 (−2.6; 5.4) −1.9 (−6.0; 2.2)
Sleep duration (min per night) 13 762 550 ± 49 2.4 (0.3; 4.4)* 4.1 (2.0; 6.2)**
Metabolic variables
HOMAIR 2005 1.46 (1.03; 2.05) 0.03 (0.005; 0.05)* 0.05 (0.02; 0.08)*
Insulin (pmol L−1) 2005 43.8 (31.6; 60.5) 0.09 (0.004; 0.18)*†† 0.15 (0.03; 0.27)*
Glucose (mmol L−1) 2057 5.2 ± 0.5 0.05 (0.005; 0.10)*†† 0.12 (0.06; 0.18)**
Mean arterial blood pressure (mmHg) 2148 79.5 ± 6.0 0.6 (0.1; 1.1)* 0.8 (0.2; 1.4)*
Diastolic blood pressure (mmHg) 2148 66.0 ± 6.4 0.7 (0.2; 1.2)* 0.9 (0.3; 1.6)*
Systolic blood pressure (mmHg) 2148 106.5 ± 7.6 0.4 (−0.2; 0.9) 0.4 (−0.3; 1.2)
Ghrelin (pg mL−1) 2028 996 ± 383 −29 (−46; −13)** −5 (−28; 18)
Leptin (pg mL−1)¶ 2017 4013 (2223; 8056) 1.2 (0.5; 1.8)** 0.7 (−0.1; 1.6)
Data are presented as unstandardized regression coefficients (β) or % difference with 95% confidence intervals using a linear mixed model with
school, class and subject as random effects and weekday, month, age, gender, Tanner stage, number of parents born in Denmark and highest
education of parents as fixed factors.
†Full moon ±4 d (Include 25 to 35% of the observations in all models).
‡±5–9 d from full moon (Include 35 to 36% of the observations in all models).
§±10–14 d from full moon (Include 29 to 39% of the observations in all models).
¶Additionally adjusted for total body fat.
††Significant associations vanished after Bonferroni adjustments.
*P < 0.05; **P < 0.001 indicate significant difference from full moon ±4 d.
HOMAIR, homeostatic model assessment of insulin resistance; PA, physical activity.
clinical obesity Sleep, activity, health and the lunar cycle A. Sjödin et al. 63
© 2015 The Authors. Clinical Obesity published by John Wiley & Sons Ltd on behalf of World Obesity. clinical obesity 5, 60–66
observed between sleep duration and HOMAIR does not fit
with HOMAIR being highest during full moon. We there-
fore speculate that any potential physiological effect of the
lunar phase is not mediated by an effect on sleep, but may
involve alterations in physical activity. These changes in
daytime activity could then subsequently alter sleep
without a direct effect of the lunar cycle.
While potential effects of the moon on daytime activity
and cardiometabolic risk factors have never been studied in
humans, an effect on sleep has been shown in three previ-
ous studies. Based on sleep logs from 31 adults over 6
weeks, Röösli et al. were the first to demonstrate that
humans slept less (19 min) at full moon compared with at
new moon (22). This finding was recently confirmed by
Cajochen et al. (4) as well as Smith et al. (5), who found
differences of 20 and 25 min using objective sleep measures
obtained from electroencephalography (EEG) monitoring
under confined laboratory conditions in 33 adults
measured for two nights and 47 adults measured for six
consecutive nights, respectively. Other researchers have
investigated this without finding an influence of the lunar
cycle on human sleep (19,23–25). Binkley et al. reported no
difference in self-reported sleep between full moon and new
moon in four adults followed for 1 year (24); Pandey et al.
found no correlation between fraction of the moon illumi-
nated and self-reported sleep in 43 adults followed for
105 d (25); and an abstract by Zeitlhofer et al. did not find
subjective ratings of sleep at full (189 nights), new (152
nights), waxing (176 nights) and waning (174 nights)
moons to differ in 391 adults followed for 14 consecutive
nights (23). Finally, Cordi et al. recently presented three
separate analyses consisting of 470, 757 and 870 nights of
EEG sleep recordings of adults which were unable to
support previous findings on sleep (19).
In the study by Cajochen et al., subjects were allowed to
sleep ad libitum without external time queues, while chil-
dren in our study were assessed over a whole week, when
they were likely woken at a fixed time on weekdays in order
to attend school. This to some extent may have defined
their sleep duration and limited our ability to find effects on
sleep duration. However, it cannot explain the small but
quite consistent longer sleep around full moon. In addition
to shorter total sleep duration around full moon, Cajochen
et al. also reported longer rapid eye movement sleep
latency, longer sleep latency, lower subjective sleep quality
and lower levels of evening melatonin during this period
(4). In support, Smith et al. reported longer sleep onset
latency, but also a shorter REM sleep latency around full
moon (5). Although accelerometers offer an objective
method to quantify sleep duration, it cannot detect the
different sleep stages. Therefore, we cannot rule out that
the longer sleep duration of the children around full moon
is a consequence of poorer sleep quality. However, as sleep
duration was measured by counting minutes below a
certain activity threshold, it is unlikely that the longer sleep
duration was caused by awakenings during the night.
The lower levels of evening melatonin, shorter sleep
duration and poorer sleep quality around full moon
observed by Cajochen et al. fits with the well-established
positive association between sleep and melatonin (26).
Recent studies indicate that low levels of melatonin are
associated with a higher risk of developing type 2 diabetes
(27), providing a link between insufficient sleep and meta-
bolic health and further indicating that the participants in
the study by Cajochen et al. (4) could also have been meta-
bolically affected by the behavioural changes observed in
response to the lunar cycle. We observed highly meaningful
physiological differences in cardiometabolic risk markers,
including glucose regulation, which fits well with the fluc-
tuations observed in moderate-to-vigorous physical activity
(7).
Using more than 13 000 d and nights of objectively
measured behaviour and more than 2000 measurements of
different cardiometabolic risk factors across nine lunar
cycles, this paper offers evidence in support of an effect of
lunar rhythmicity on human behaviour and metabolic
health. On average, each child had valid activity and sleep
recordings from 17 d and 18 nights used in the analyses.
Further, we adjusted for a large number of potential con-
founders shown to affect physical activity and sleep dura-
tion in this group of children (9). Finally, the linear mixed
model approach removes differences between children
before estimates are calculated. Therefore, it is very
unlikely that our findings could be explained by other
sources of variation (e.g. uneven distribution of age and
gender), as might have been the case in the study by
Cajochen et al., where there were almost three times as
many older subjects around full moon compared with new
moon (4). However, we lack strong hypotheses regarding
plausible mechanisms that can explain the association
between the lunar phases and variation in daytime activity
and/or sleep. Several publications on the various influences
of lunar phases discuss the potential role of variations in
gravitational forces that, e.g., in some areas of the world
have considerable effects on water, seen as tides. The tides
are affected by the combined gravitational forces exerted
by the moon and the sun as well as the rotation of the earth,
which result in rises and falls of water levels every 12.4 h.
Spring tides (higher than normal tides) and neap tides (high
tides are lower than normal and low tides are higher than
normal) are showing semi-lunar cycles (∼14.8 d) with
spring tides peaking at full and new moon and neap tides
peaking at half moon (28). However, as we find large
differences in behaviour and metabolic risk markers
between full moon ±4 d and ±10–14 d from full moon,
periods that both coincide with spring tides, these gravita-
tional forces cannot explain our findings. Further, these
forces are said to be remarkably weak (1).
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In the same group of children, we have previously
reported shorter sleep duration during periods of the year
with longer photoperiods (day length) (9), which leads us
to yet another proposed mechanism involving differences in
light exposure during the night, which is known to affect
sleep (29). At full moon during a clear night, illuminance
may be around 25 times greater than at half moon and up
to 250 times greater compared with a moonless night. In
modern urban societies where most of us are surrounded by
an abundance of artificial light and spend evenings and
nights mostly indoors, this effect is probably minor (1) and
light in the late evening and at night is unlikely to have an
effect on physical activity during the time awake.
The results suggest that physical activity rather than
sleep is responsible for the metabolic alterations observed
around full moon. However, at the moment, we have no
understanding of potential mechanisms that may mediate a
potential true link between childhood behaviour and the
lunar cycle or of confounders that may provide alternative
explanations for the associations we found between lunar
phases and behaviour apparently leading to fluctuation in a
number of cardiometabolic risk markers conjointly with
lunar phases. Solving the lunar mystery could lead to novel,
fascinating and unexpected insight into the effects of the
environment on human behaviour and our physiology in
general.
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